Rc. Smallridge et al., Renal metastases from thyroid papillary carcinoma: Study of sodium iodide symporter expression, THYROID, 11(8), 2001, pp. 795-804
Kidney metastases from thyroid cancer are rare. We report two such patients
and demonstrate that the in vivo I-131 uptake by the kidney metastasis is
associated with high levels of sodium iodide (Na+/I-) symporter (NIS) expre
ssion in the first case. Case 1: A 61-year-old woman with papillary thyroid
carcinoma-follicular variant (PTC-FV) presented with scapular metastasis.
After thyroidectomy and scapulectomy, a I-131 posttherapy scan showed left
upper quadrant uptake. A 3.0-cm metastatic PTC-FV deposit was removed by pa
rtial nephrectomy. Case 2: A 53-year-old woman presented with back pain. A
computed tomography (CT) scan showed a 3.5-cm renal mass, a multinodular go
iter, and lung metastases thought secondary to a renal cell carcinoma. A un
ilateral nephrectomy revealed metastatic PTC-FV. After thyroidectomy, a I-1
31 posttherapy scan showed lung and skeletal metastases. NIS immunoreactivi
ty in tumoral tissue was strongly positive in the primary tumor, shoulder,
and kidney metastasis in case 1, as well as in the primary tumor in case 2.
Spotty, low-level NIS expression was observed in the kidney metastasis in
case 2. In conclusion, kidney metastases of PTC-FV may occasionally retain
adequate levels of NIS expression, enabling their detection during life. Th
us, intense uptake in the abdomen during I-131 imaging should not be assume
d to be physiological gastrointestinal tract residual radionuclide activity
.